COVID-19 epidemiology and variants (Record no. 75838)

000 -LEADER
fixed length control field 02479nim a2200529 a 4500
001 - CONTROL NUMBER
control field HST8216
003 - CONTROL NUMBER IDENTIFIER
control field UkLoHST
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o h
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nna||||||||
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field sr |mnnnnnzne|
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210304s2021 enk|||||o||h||||||||eng d
028 50 - PUBLISHER NUMBER
Publisher number 8216
Source Henry Stewart Talks
035 ## - SYSTEM CONTROL NUMBER
System control number (UkLoHST)4580
040 ## - CATALOGING SOURCE
Original cataloging agency UkLoHST
Language of cataloging eng
Transcribing agency UkLoHST
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Baric, Ralph,
Affiliation (University of North Carolina at Chapel Hill, USA)
Relator code spk
245 10 - TITLE STATEMENT
Title COVID-19 epidemiology and variants
Medium [electronic resource] :
Remainder of title new challenges and future of the pandemic /
Statement of responsibility, etc. an interview with Ralph Baric.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. London :
Name of publisher, distributor, etc. Henry Stewart Talks,
Date of publication, distribution, etc. 2021.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (1 streaming audio file (18 min.)).
490 1# - SERIES STATEMENT
Series statement Interviews on Covid-19,
International Standard Serial Number 2056-452X
500 ## - GENERAL NOTE
General note Audio interview.
500 ## - GENERAL NOTE
General note Title from title frames.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Contents: Emergence of new variants and their new evolutionarily advantageous traits -- Probability of the emergence of additional variants and a new strain of SARS-CoV-2 -- Potential immune escape mechanisms of a theoretical new SARS-CoV-2 strain -- What can governments and individuals do to reduce the probability of emergence of additional variants -- Efficacy shown to date by COVID-19 vaccines and their projected impact in controlling the pandemic -- Update on current COVID-19 treatments (including convalescent antibody therapy, Remdesivir and dexamethasone) and the importance of the time window for their administration.
506 ## - RESTRICTIONS ON ACCESS NOTE
Terms governing access Access restricted to subscribers.
538 ## - SYSTEM DETAILS NOTE
System details note Mode of access: World Wide Web.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Coronaviruses.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element COVID-19 (Disease)
General subdivision Epidemiology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element COVID-19 (Disease)
General subdivision Research.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element COVID-19 Pandemic, 2020-
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Coronavirus Infections.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element COVID-19 Vaccines.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element COVID-19
General subdivision epidemiology.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element COVID-19
General subdivision transmission.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element COVID-19
General subdivision virology.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Dexamethasone.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug Development.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug Resistance, Viral.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Genetic Variation.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Mutation.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pandemics.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element remdesivir.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element SARS-CoV-2 variants.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element SARS-CoV-2
General subdivision genetics.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element SARS-CoV-2
General subdivision pathogenicity.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Henry Stewart talks.
Name of part/section of a work Biomedical & life sciences collection.
-- Interviews on Covid-19.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://hstalks.com/bs/4580/">https://hstalks.com/bs/4580/</a>
856 42 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://hstalks.com/bs/p/1060/">https://hstalks.com/bs/p/1060/</a>
Materials specified Series

No items available.

Technical University of Mombasa
Tom Mboya Street, Tudor 90420-80100 , Mombasa Kenya
Tel: (254)41-2492222/3 Fax: 2490571